TipRanks
WellCell Holdings Co., Limited (HK:2477)
:2477
Hong Kong Market
Want to see HK:2477 full AI Analyst Report?

WellCell Holdings Co., Limited (2477) AI Stock Analysis

0 Followers

Top Page

HK:2477

WellCell Holdings Co., Limited

(2477)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - Gpt-5.6Sol)
Rating:42Neutral
Price Target:
HK$0.20
▼(-98.42% Downside)
Action:Reiterated
Date:08/18/26
The score is primarily held down by deteriorating financial performance—especially negative operating/free cash flow and the sharp 2025 margin and revenue reset—despite a comparatively manageable leverage profile. Technicals add limited support due to mixed momentum signals, while valuation is a significant headwind given the very high P/E and no dividend yield provided.
Positive Factors
Manageable leverage
Debt-to-equity of about 0.15 in 2025, improved versus 2022–2023, indicates limited balance-sheet leverage. That relative resilience can preserve financing flexibility and reduce the burden of debt service while the company works through weaker profitability and cash generation.
Negative Factors
Revenue and margin deterioration
The 2025 revenue contraction and severe gross-margin compression indicate a broad operating reset rather than a minor fluctuation. Negative EBIT shows that the core business is not currently converting sales into operating profit, creating a material challenge for recovery and margin sustainability.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable leverage
Debt-to-equity of about 0.15 in 2025, improved versus 2022–2023, indicates limited balance-sheet leverage. That relative resilience can preserve financing flexibility and reduce the burden of debt service while the company works through weaker profitability and cash generation.
Read all positive factors

WellCell Holdings Co., Limited (2477) vs. iShares MSCI Hong Kong ETF (EWH)

WellCell Holdings Co., Limited Business Overview & Revenue Model

Company Description
WellCell Holdings Co., Limited, operating through its various subsidiaries, is a key provider of telecommunication network support and integrated information and communication technology (ICT) services across the People's Republic of China. The co...

WellCell Holdings Co., Limited Financial Statement Overview

Summary
Financial performance is weakened by a sharp 2025 revenue decline (-18.8%), major margin compression (gross margin ~4.8%), and negative operating profitability (EBIT margin ~-5.5%). The balance sheet is relatively resilient with manageable leverage (debt-to-equity ~0.15), but negative operating and free cash flow in 2024–2025 is a key risk, especially alongside positive net income, which raises earnings-quality concerns.
Income Statement
48
Neutral
Balance Sheet
72
Positive
Cash Flow
27
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue313.77M212.87M278.22M255.96M226.51M203.34M
Gross Profit-11.29M10.15M56.72M61.61M66.70M87.58M
EBITDA-61.12M-4.16M25.88M26.31M33.23M32.80M
Net Income-50.77M14.94M20.14M20.40M24.26M25.52M
Balance Sheet
Total Assets291.08M330.97M325.32M183.59M163.18M149.86M
Cash, Cash Equivalents and Short-Term Investments49.73M54.95M116.58M23.81M42.20M21.54M
Total Debt49.28M31.65M43.98M28.14M30.08M8.29M
Total Liabilities117.45M115.80M124.95M98.44M82.44M78.78M
Stockholders Equity173.55M214.90M200.37M85.15M80.74M71.09M
Cash Flow
Free Cash Flow-29.08M-35.01M-38.60M5.96M15.67M23.00M
Operating Cash Flow-24.60M-19.79M-15.95M6.03M16.96M25.02M
Investing Cash Flow-17.65M-16.81M-20.73M131.00K-1.20M-3.79M
Financing Cash Flow12.64M-14.28M117.90M-24.55M4.89M-22.82M

WellCell Holdings Co., Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price12.33
Price Trends
50DMA
0.22
Negative
100DMA
0.40
Negative
200DMA
1.99
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
44.38
Neutral
STOCH
23.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2477, the sentiment is Neutral. The current price of 12.33 is above the 20-day moving average (MA) of 0.20, above the 50-day MA of 0.22, and above the 200-day MA of 1.99, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 44.38 is Neutral, neither overbought nor oversold. The STOCH value of 23.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2477.

WellCell Holdings Co., Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
HK$90.69B17.0914.86%6.92%7.09%4.21%
73
Outperform
HK$5.31B10.279.66%6.65%5.60%9.64%
63
Neutral
HK$5.23B-264.630.25%6.87%23.04%-192.00%
60
Neutral
$48.67B4.58-11.27%4.14%2.83%-41.78%
54
Neutral
HK$40.07B-474.77-6.77%7.39%7.10%70.22%
53
Neutral
HK$8.62B41.479.40%5.90%8.01%58.51%
42
Neutral
HK$973.59M-12.34-26.14%―-17.16%-313.04%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2477
WellCell Holdings Co., Limited
0.20
-2.72
-93.06%
HK:1310
HKBN
5.83
-0.11
-1.82%
HK:6823
HKT and HKT
11.96
0.99
9.04%
HK:0215
Hutchison Telecommunications Hong Kong Holdings
1.09
0.09
9.15%
HK:0315
SmarTone Telecommunications Holdings
4.83
0.46
10.41%
HK:0008
PCCW Limited
5.18
0.05
1.02%

WellCell Holdings Co., Limited Corporate Events

WellCell Reshapes Board as Three Directors Exit and New INED Joins
Sep 28, 2026
WellCell Holdings announced a series of boardroom changes effective 28 September 2026, including the resignation of executive director Zhang Xiaolong and independent non-executive directors (INEDs) Chan Wai Dune and Dan Xi, who are stepping down t...
WellCell Sets Out Board Composition and Committee Roles
Sep 28, 2026
WellCell Holdings Co., Limited has announced the current composition of its board of directors, comprising executive directors Qian Fenglei, who serves as chairman, and Jia Zhengyi, alongside independent non-executive directors Wu Hung Yuk Anna an...
WellCell Holdings Swings to Interim Loss as Costs and Other Losses Hit Earnings
Aug 31, 2026
WellCell Holdings Co., Limited, a Cayman Islands-incorporated issuer listed on the Hong Kong Stock Exchange, operates through a project-based services model that depends substantially on subcontracting, materials, and related project costs. Its in...
WellCell Sets Board Meeting to Approve Interim Results and Consider Dividend
Aug 19, 2026
WellCell Holdings Co., Limited, a Cayman Islands–incorporated company listed in Hong Kong, operates under a board structure with three executive directors and three independent non-executive directors. The governance framework, headed by cha...
WellCell flags interim loss as telecoms weaken and AI push lifts costs
Aug 17, 2026
WellCell Holdings Co., Limited has warned that it expects to swing to a net loss of up to RMB45 million for the six months ended 30 June 2026, compared with a profit of about RMB7.7 million a year earlier. The company cites fair value losses on fi...
WellCell raises HK$188 million via share placing and top-up subscription to fund computing platform
Jul 16, 2026
WellCell Holdings has completed a placing of 796 million existing shares at HK$0.24 each through Beta International Securities, distributing them to at least six independent investors without any new substantial shareholder emerging. Immediately a...
WellCell Launches Major Share Placing and Top-Up Subscription at HK$0.24
Jul 13, 2026
WellCell Holdings Co., Limited has announced a placing of up to 796 million existing shares at HK$0.24 each by a substantial shareholder, with the shares to be sold via Beta International Securities to at least six independent investors. The move ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 18, 2026